Targeting melanoma with HIV?

Article

Los Angeles — A modified form of the HIV virus has been shown to be effective in targeting melanoma in animal models, according to a study published in Nature Medicine in February.

Related Videos
Related Content

The Retirement “Red Zone”: What You Need to Know to Score Financially

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Journal Digest: September 26

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Retirement “Red Zone”: What You Need to Know to Score Financially

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Journal Digest: September 26

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Retirement “Red Zone”: What You Need to Know to Score Financially

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Journal Digest: September 26

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.